Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Cardiac Biomarker Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Creatine kinase (CK) MB
  • 1.3.3 Troponin (cTnI and cTnT)
  • 1.3.4 BNP & NT-proBNP
  • 1.3.5 Myogloblin
  • 1.3.6 Others (hs-CRP, D-Dimer, etc.)
• 1.4 Market Segment by Application
  • 1.4.1 Global Cardiac Biomarker Market Share by Application (2019-2025)
  • 1.4.2 Myocardial Infarction
  • 1.4.3 Congestive Heart Failure
  • 1.4.4 Acute Coronary Syndrome
  • 1.4.5 Atherosclerosis
  • 1.4.6 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Cardiac Biomarker Market Size
  • 2.1.1 Global Cardiac Biomarker Revenue 2014-2025
  • 2.1.2 Global Cardiac Biomarker Sales 2014-2025
• 2.2 Cardiac Biomarker Growth Rate by Regions
  • 2.2.1 Global Cardiac Biomarker Sales by Regions 2014-2019
  • 2.2.2 Global Cardiac Biomarker Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Cardiac Biomarker Sales by Manufacturers
  • 3.1.1 Cardiac Biomarker Sales by Manufacturers 2014-2019
  • 3.1.2 Cardiac Biomarker Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Cardiac Biomarker Revenue by Manufacturers (2014-2019)
  • 3.2.2 Cardiac Biomarker Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Cardiac Biomarker Market Concentration Ratio (CR5 and HHI)
• 3.3 Cardiac Biomarker Price by Manufacturers
• 3.4 Key Manufacturers Cardiac Biomarker Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Cardiac Biomarker Market
• 3.6 Key Manufacturers Cardiac Biomarker Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Creatine kinase (CK) MB Sales and Revenue (2014-2019)
  • 4.1.2 Troponin (cTnI and cTnT) Sales and Revenue (2014-2019)
  • 4.1.3 BNP & NT-proBNP Sales and Revenue (2014-2019)
  • 4.1.4 Myogloblin Sales and Revenue (2014-2019)
  • 4.1.5 Others (hs-CRP, D-Dimer, etc.) Sales and Revenue (2014-2019)
• 4.2 Global Cardiac Biomarker Sales Market Share by Type
• 4.3 Global Cardiac Biomarker Revenue Market Share by Type
• 4.4 Cardiac Biomarker Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Cardiac Biomarker Sales by Application

6 United States

• 6.1 United States Cardiac Biomarker Breakdown Data by Company
• 6.2 United States Cardiac Biomarker Breakdown Data by Type
• 6.3 United States Cardiac Biomarker Breakdown Data by Application

7 European Union

• 7.1 European Union Cardiac Biomarker Breakdown Data by Company
• 7.2 European Union Cardiac Biomarker Breakdown Data by Type
• 7.3 European Union Cardiac Biomarker Breakdown Data by Application

8 China

• 8.1 China Cardiac Biomarker Breakdown Data by Company
• 8.2 China Cardiac Biomarker Breakdown Data by Type
• 8.3 China Cardiac Biomarker Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Cardiac Biomarker Breakdown Data by Company
• 9.2 Rest of World Cardiac Biomarker Breakdown Data by Type
• 9.3 Rest of World Cardiac Biomarker Breakdown Data by Application
• 9.4 Rest of World Cardiac Biomarker Breakdown Data by Countries
  • 9.4.1 Rest of World Cardiac Biomarker Sales by Countries
  • 9.4.2 Rest of World Cardiac Biomarker Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Alere
  • 10.1.1 Alere Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Cardiac Biomarker
  • 10.1.4 Cardiac Biomarker Product Introduction
  • 10.1.5 Alere Recent Development
• 10.2 Roche Diagnostics
  • 10.2.1 Roche Diagnostics Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Cardiac Biomarker
  • 10.2.4 Cardiac Biomarker Product Introduction
  • 10.2.5 Roche Diagnostics Recent Development
• 10.3 BG Medicine
  • 10.3.1 BG Medicine Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Cardiac Biomarker
  • 10.3.4 Cardiac Biomarker Product Introduction
  • 10.3.5 BG Medicine Recent Development
• 10.4 Biomerieux
  • 10.4.1 Biomerieux Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Cardiac Biomarker
  • 10.4.4 Cardiac Biomarker Product Introduction
  • 10.4.5 Biomerieux Recent Development
• 10.5 Critical Diagnostics
  • 10.5.1 Critical Diagnostics Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Cardiac Biomarker
  • 10.5.4 Cardiac Biomarker Product Introduction
  • 10.5.5 Critical Diagnostics Recent Development
• 10.6 DiaDexus
  • 10.6.1 DiaDexus Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Cardiac Biomarker
  • 10.6.4 Cardiac Biomarker Product Introduction
  • 10.6.5 DiaDexus Recent Development
• 10.7 Response Biomedical
  • 10.7.1 Response Biomedical Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Cardiac Biomarker
  • 10.7.4 Cardiac Biomarker Product Introduction
  • 10.7.5 Response Biomedical Recent Development
• 10.8 Siemens Healthcare
  • 10.8.1 Siemens Healthcare Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Cardiac Biomarker
  • 10.8.4 Cardiac Biomarker Product Introduction
  • 10.8.5 Siemens Healthcare Recent Development
• 10.9 Singulex
  • 10.9.1 Singulex Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Cardiac Biomarker
  • 10.9.4 Cardiac Biomarker Product Introduction
  • 10.9.5 Singulex Recent Development
• 10.10 Thermo Scientific
  • 10.10.1 Thermo Scientific Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Cardiac Biomarker
  • 10.10.4 Cardiac Biomarker Product Introduction
  • 10.10.5 Thermo Scientific Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Cardiac Biomarker Sales Channels
  • 11.2.2 Cardiac Biomarker Distributors
• 11.3 Cardiac Biomarker Customers

12 Market Forecast

• 12.1 Global Cardiac Biomarker Sales and Revenue Forecast 2019-2025
• 12.2 Global Cardiac Biomarker Sales Forecast by Type
• 12.3 Global Cardiac Biomarker Sales Forecast by Application
• 12.4 Cardiac Biomarker Forecast by Regions
  • 12.4.1 Global Cardiac Biomarker Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Cardiac Biomarker Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Cardiac Biomarker is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cardiac Biomarker.

This report studies the global market size of Cardiac Biomarker, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Cardiac Biomarker sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Alere
Roche Diagnostics
BG Medicine
Biomerieux
Critical Diagnostics
DiaDexus
Response Biomedical
Siemens Healthcare
Singulex
Thermo Scientific

Market Segment by Product Type
Creatine kinase (CK) MB
Troponin (cTnI and cTnT)
BNP & NT-proBNP
Myogloblin
Others (hs-CRP, D-Dimer, etc.)

Market Segment by Application
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Cardiac Biomarker status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Cardiac Biomarker manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Cardiac Biomarker are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025